
Chembio Diagnostics is a diagnostics & research business based in the US. Chembio Diagnostics shares (CEMI) are listed on the NASDAQ and all prices are listed in US Dollars. Chembio Diagnostics employs 337 staff and has a trailing 12-month revenue of around $59.8 million.
How to buy Chembio Diagnostics stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – CEMI. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
eToro
- Trade stocks and ETFs for $0 and no annual fee
- Minimum deposit of $10 required
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Chembio Diagnostics stock price (NASDAQ: CEMI)
Use our graph to track the performance of CEMI stocks over time.Chembio Diagnostics shares at a glance
Latest market close | $0.44 |
---|---|
52-week range | $0.19 - $1.24 |
50-day moving average | $0.29 |
200-day moving average | $0.52 |
Wall St. target price | $8.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.43 |
Buy Chembio Diagnostics stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Chembio Diagnostics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Chembio Diagnostics price performance over time
Historical closes compared with the close of $0.44 from 2023-02-01
1 week (2023-01-27) | 25.71% |
---|---|
1 month (2022-12-30) | N/A |
3 months (2022-10-30) | N/A |
6 months (2022-07-30) | N/A |
1 year (2022-02-03) | -53.19% |
---|---|
2 years (2021-02-03) | -94.02% |
3 years (2020-02-03) | 4.09 |
5 years (2018-02-02) | 8.2 |
Chembio Diagnostics financials
Revenue TTM | $59.8 million |
---|---|
Gross profit TTM | $12.8 million |
Return on assets TTM | -22% |
Return on equity TTM | -110.81% |
Profit margin | -60.93% |
Book value | $0.50 |
Market capitalisation | $13.2 million |
TTM: trailing 12 months
Chembio Diagnostics share dividends
We're not expecting Chembio Diagnostics to pay a dividend over the next 12 months.
Have Chembio Diagnostics's shares ever split?
Chembio Diagnostics's shares were split on a 1:8 basis on 29 May 2012. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Chembio Diagnostics shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Chembio Diagnostics shares which in turn could have impacted Chembio Diagnostics's share price.
Chembio Diagnostics share price volatility
Over the last 12 months, Chembio Diagnostics's shares have ranged in value from as little as $0.19 up to $1.24. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Chembio Diagnostics's is 1.7196. This would suggest that Chembio Diagnostics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Chembio Diagnostics overview
Chembio Diagnostics, Inc. , together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.
Chembio Diagnostics in the news
French Rapid Testing Company Scoops Up Chembio Diagnostics For $17M
Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement
Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement
Frequently asked questions
What percentage of Chembio Diagnostics is owned by insiders or institutions?Currently 1.077% of Chembio Diagnostics shares are held by insiders and 8.601% by institutions. How many people work for Chembio Diagnostics?
Latest data suggests 337 work at Chembio Diagnostics. When does the fiscal year end for Chembio Diagnostics?
Chembio Diagnostics's fiscal year ends in December. Where is Chembio Diagnostics based?
Chembio Diagnostics's address is: 555 Wireless Boulevard, Hauppauge, NY, United States, 11788 What is Chembio Diagnostics's ISIN number?
Chembio Diagnostics's international securities identification number is: US1635722093 What is Chembio Diagnostics's CUSIP number?
Chembio Diagnostics's Committee on Uniform Securities Identification Procedures number is: 163572209
More guides on Finder
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert